RVTY

Latest SEC Filings & News for RVTY

1 most recent filing and news item mentioning RVTY. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/RVTY/news?limit=20"

Pull RVTY filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Revvity reports strong second-quarter results and raises full-year guidance.

Revvity reported a 4% pro forma revenue growth and raised full-year guidance for 2026, while entering a definitive agreement to divest its China immunodiagnostics business.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.